AMWatch

Portfolio Manager leaves BankInvest to take on IR in the healthcare industry

Member of the Investment Board and former healthcare sector specialist at Denmark's bank-owned asset manager joins pharmaceutical company as Investor Relations Manager.

Photo: Peter Helles Eriksen / Ritzau Scanpix

Kasper Lytthans has decided to leave BankInvest after having climbed the career ladder for close to 13 years at the EUR 14.2bn Copenhagen-based asset manager, he reveals on LinkedIn.

Lytthans began as Analyst in 2006 and ended as Co-manager of the global equity portfolios and Member of the Investment Board. Additionally, he was responsible for stock selection in the industrials and materials sectors.

"I am excited and proud to announce that I will join Abacus Medicine as Investor Relations Manager on the 15th of August," Lytthans writes on the social media platform.

"I would like to use the opportunity to thank my former colleagues at BankInvest. I have had a fantastic journey, learned a lot, and wish you all the best in the challenging markets," he adds.

According to BankInvest Head of Corporate Communication Dag Holmstad, Lytthans was Portfolio Manager for the strategies Global Equities and Basic Global Equities.

"We wish Kasper all the best in his new position and remain grateful for his strong efforts over the years,” Holmstad tells AMWatch.

Holmstad adds that BankInvest has hired a replacement for the global equities team, and that the new recruitment will be disclosed later in August.

Related articles

amwatch trial

Latest news

Jobs

See all

See all

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch